The Short-term Verbal Memory Endophenotype for Developmental Language Disorder Language Disorder
Father Flanagan's Boys' Home · with University of Iowa, National Institutes of Health (NIH) · NCT06968169
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 5–10 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 120
- US sites recruiting
- 1
- Study start
- February 9, 2025
- Record last updated
- May 13, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to determine how memory and attention affect the ability of children with developmental language disorder (DLD) to learn and use new vocabulary.
Being studied: Supportive learning; Cascades
Conditions: Developmental Language Disorder; Healthy Subjects
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Has DLD or typical language development
Exclusion Criteria
- Has not been exposed to English since birth
- Has other neurodevelopmental or sensory condition that could explain the language problem (e.g., intellectual disability, autism, hearing loss).
Recruiting US locations
Boys Town National Research Hospital
Omaha, NE 68131
Study contacts (from the official record)
- Principal Investigator · 531-355-5068 · karla.mcgregor@boystown.org
- Lab Manager · 531-355-5096 · margo.appenzeller@boystown.org
Similar studies in Nebraska
All healthy volunteers studies in Nebraska →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Grand Island, NE + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1
A Study of V132 in Healthy Older Participants (V132-001)
Merck Sharp & Dohme LLC
- Location
- Lincoln, NE + 9 other US sites
- Eligibility basics
- Ages 50–75
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Lincoln, NE + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).
Merck Sharp & Dohme LLC
- Location
- Lincoln, NE + 5 other US sites
- Eligibility basics
- Ages 12–30